261 related articles for article (PubMed ID: 23008318)
1. Long-term and late effects of germ cell testicular cancer treatment and implications for follow-up.
Haugnes HS; Bosl GJ; Boer H; Gietema JA; Brydøy M; Oldenburg J; Dahl AA; Bremnes RM; Fosså SD
J Clin Oncol; 2012 Oct; 30(30):3752-63. PubMed ID: 23008318
[TBL] [Abstract][Full Text] [Related]
2. Treatment-specific risks of second malignancies and cardiovascular disease in 5-year survivors of testicular cancer.
van den Belt-Dusebout AW; de Wit R; Gietema JA; Horenblas S; Louwman MW; Ribot JG; Hoekstra HJ; Ouwens GM; Aleman BM; van Leeuwen FE
J Clin Oncol; 2007 Oct; 25(28):4370-8. PubMed ID: 17906202
[TBL] [Abstract][Full Text] [Related]
3. Pulmonary and cardiovascular toxicity in long-term testicular cancer survivors.
Haugnes HS; Oldenburg J; Bremnes RM
Urol Oncol; 2015 Sep; 33(9):399-406. PubMed ID: 25554583
[TBL] [Abstract][Full Text] [Related]
4. Long-term Morbidity of Testicular Cancer Treatment.
Fung C; Fossa SD; Williams A; Travis LB
Urol Clin North Am; 2015 Aug; 42(3):393-408. PubMed ID: 26216826
[TBL] [Abstract][Full Text] [Related]
5. Sequelae of treatment in long-term survivors of testis cancer.
Abouassaly R; Fossa SD; Giwercman A; Kollmannsberger C; Motzer RJ; Schmoll HJ; Sternberg CN
Eur Urol; 2011 Sep; 60(3):516-26. PubMed ID: 21684072
[TBL] [Abstract][Full Text] [Related]
6. Medical treatment of advanced testicular cancer.
Feldman DR; Bosl GJ; Sheinfeld J; Motzer RJ
JAMA; 2008 Feb; 299(6):672-84. PubMed ID: 18270356
[TBL] [Abstract][Full Text] [Related]
7. [Long-term complications following treatment of testicular cancer and Hodgkin lymphoma].
van den Belt-Dusebout AW; Aleman BM; Gietema JA; de Wit R; van 't Veer MB; Lugtenburg PJ; Krol AD; van Leeuwen FE
Ned Tijdschr Geneeskd; 2010; 154(45):A2229. PubMed ID: 21118593
[TBL] [Abstract][Full Text] [Related]
8. Short- and long-term morbidity after treatment for testicular cancer.
Fosså SD; Oldenburg J; Dahl AA
BJU Int; 2009 Nov; 104(9 Pt B):1418-22. PubMed ID: 19840023
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular risk factors and morbidity in long-term survivors of testicular cancer: a 20-year follow-up study.
Haugnes HS; Wethal T; Aass N; Dahl O; Klepp O; Langberg CW; Wilsgaard T; Bremnes RM; Fosså SD
J Clin Oncol; 2010 Oct; 28(30):4649-57. PubMed ID: 20855830
[TBL] [Abstract][Full Text] [Related]
10. The graying of testis cancer patients: what have we learned?
Bajorin DF
J Clin Oncol; 2007 Oct; 25(28):4341-3. PubMed ID: 17906197
[No Abstract] [Full Text] [Related]
11. Treatment-related cardiovascular late effects and exercise training countermeasures in testicular germ cell cancer survivorship.
Christensen JF; Bandak M; Campbell A; Jones LW; Højman P
Acta Oncol; 2015 May; 54(5):592-9. PubMed ID: 25751759
[TBL] [Abstract][Full Text] [Related]
12. Secondary malignant neoplasms in testicular cancer survivors.
Curreri SA; Fung C; Beard CJ
Urol Oncol; 2015 Sep; 33(9):392-8. PubMed ID: 26072728
[TBL] [Abstract][Full Text] [Related]
13. Intermediate and long-term complications associated with adjuvant chemotherapy for stage I germ cell tumor patients.
Suarez-Ibarrola R; Abufaraj M; Shariat SF
Curr Opin Urol; 2018 Sep; 28(5):485-490. PubMed ID: 30044319
[TBL] [Abstract][Full Text] [Related]
14. Long-term mortality from second malignant neoplasms in 5-year survivors of solid childhood tumors: temporal pattern of risk according to type of treatment.
Tukenova M; Diallo I; Hawkins M; Guibout C; Quiniou E; Pacquement H; Dhermain F; Shamsaldin A; Oberlin O; de Vathaire F
Cancer Epidemiol Biomarkers Prev; 2010 Mar; 19(3):707-15. PubMed ID: 20200431
[TBL] [Abstract][Full Text] [Related]
15. [Risk of secondary neoplasia after treatment of malignant germ cell tumors of the testis].
Bokemeyer C; Kuczyk MA; Köhne CH; Haupt A; Schmoll HJ
Med Klin (Munich); 1996 Nov; 91(11):703-10. PubMed ID: 9036294
[No Abstract] [Full Text] [Related]
16. Testicular cancer patients: considerations in long-term follow-up.
Gospodarowicz M
Hematol Oncol Clin North Am; 2008 Apr; 22(2):245-55, vi. PubMed ID: 18395148
[TBL] [Abstract][Full Text] [Related]
17. Long-term toxicity of the treatment for germ cell-cancer. A review.
Maroto P; Anguera G; Martin C
Crit Rev Oncol Hematol; 2018 Jan; 121():62-67. PubMed ID: 29279100
[TBL] [Abstract][Full Text] [Related]
18. Review of late complications of treatment and late relapse in testicular cancer.
Efstathiou E; Logothetis CJ
J Natl Compr Canc Netw; 2006 Nov; 4(10):1059-70. PubMed ID: 17112453
[TBL] [Abstract][Full Text] [Related]
19. Toxicity of treatment of germ cell tumors.
Boyer M; Raghavan D
Semin Oncol; 1992 Apr; 19(2):128-42. PubMed ID: 1313191
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular events in survivors of high-dose chemotherapy for germ cell tumors.
Ishioka J; Fujii Y; Kageyama Y; Fukuda H; Higashi Y; Kihara K
Int J Urol; 2008 Jul; 15(7):642-5. PubMed ID: 18643784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]